Very Low-Gradient Aortic Stenosis Carries Worse TAVI Outcomes Regardless of Flow State
A 7,103-patient Japanese registry shows very low-gradient aortic stenosis independently predicts higher mortality and heart failure after TAVI.
Summary
A large multicenter Japanese registry (OCEAN-TAVI) followed 7,103 patients who underwent transcatheter aortic valve implantation (TAVI) and categorized them by baseline mean pressure gradient: very low-gradient (≤20 mmHg), low-gradient (20–40 mmHg), and high-gradient (≥40 mmHg). Over a median follow-up of about two years, patients in the very low-gradient group fared significantly worse — reaching the composite endpoint of death or heart failure hospitalization more often than either other group. Importantly, this risk was independent of cardiac flow status, meaning it could not be explained simply by reduced ejection fraction or low-flow physiology. Low body mass index and prior heart attack further worsened outcomes within this subgroup. The findings highlight that very low-gradient severe aortic stenosis represents a distinct, high-risk phenotype even after successful valve replacement.
Detailed Summary
Aortic stenosis is among the most common age-related valvular heart diseases, and transcatheter aortic valve implantation (TAVI) has become the dominant treatment, particularly in older adults. While much is known about outcomes after TAVI in patients with high-gradient stenosis, patients presenting with very low pressure gradients across a severely narrowed valve have remained poorly characterized — and managing them is genuinely difficult because low gradients can reflect either mild disease or severely impaired cardiac function.
This retrospective study drew on the OCEAN-TAVI multicenter registry, one of Japan's largest real-world TAVI databases. Among 7,103 patients who underwent TAVI, investigators stratified cases into three groups based on mean pressure gradient (MPG): very low-gradient (MPG ≤20 mmHg), low-gradient (20–40 mmHg), and high-gradient (≥40 mmHg). The primary composite endpoint was all-cause mortality or hospitalization for heart failure, tracked over a median of 741 days.
Patients with very low-gradient stenosis carried a heavier burden of comorbidities at baseline. Kaplan-Meier survival curves showed significantly lower event-free survival in this group compared to both other categories. Multivariable Cox regression confirmed that very low-gradient classification was an independent predictor of worse outcomes — not explained by whether patients had low or normal flow states. Within the very low-gradient group, low body mass index and a history of myocardial infarction were additional independent markers of poor prognosis.
These findings are clinically important for aging populations where aortic stenosis prevalence rises steeply after age 65. The data suggest that very low-gradient presentation should prompt intensified post-procedural surveillance and risk factor management, rather than reassurance that TAVI has resolved the problem.
Caveats include the retrospective design, the registry's Japanese-only population limiting generalizability, and the fact that this summary is based on the abstract alone, so full covariate adjustment details and subgroup analyses cannot be evaluated.
Key Findings
- Very low-gradient aortic stenosis (MPG ≤20 mmHg) independently predicts worse survival after TAVI versus low- or high-gradient disease.
- The elevated risk persisted regardless of cardiac flow status, ruling out low-flow physiology as the sole driver.
- Low BMI and prior myocardial infarction further worsened outcomes specifically within the very low-gradient subgroup.
- Over two years, 2,081 of 7,103 TAVI patients reached the composite endpoint of death or heart failure hospitalization.
- Very low-gradient patients carried significantly higher comorbidity burden at baseline compared to other groups.
Methodology
Retrospective analysis of 7,103 patients from the OCEAN-TAVI multicenter registry across multiple Japanese centers. Patients were stratified by baseline mean pressure gradient into three groups and followed for a median of 741 days. Primary analysis used Kaplan-Meier survival curves and multivariable Cox proportional hazards regression.
Study Limitations
The retrospective registry design limits causal inference, and enrollment from Japanese centers only may restrict generalizability to other ethnic and clinical populations. Full methodological details, covariate definitions, and subgroup analyses are unavailable as this summary is based on the abstract only.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: